Shengshan Xu
- Topics
- RNA modifications and cancer (4 papers)Ferroptosis and cancer prognosis (4 papers)Cancer Immunotherapy and Biomarkers (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
In The Last Decade
Shengshan Xu
13 papers receiving 175 citations
Hit Papers
Peers
Comparison fields: 5 of 36
- Molecular Biology 85
- Oncology 56
- Cancer Research 43
- Pulmonary and Respiratory Medicine 39
- Immunology 37
Countries citing papers authored by Shengshan Xu
This map shows the geographic impact of Shengshan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengshan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengshan Xu more than expected).
Fields of papers citing papers by Shengshan Xu
This network shows the impact of papers produced by Shengshan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengshan Xu. The network helps show where Shengshan Xu may publish in the future.
Co-authorship network of co-authors of Shengshan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shengshan Xu. A scholar is included among the top collaborators of Shengshan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengshan Xu. Shengshan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysisbreakdown → | 20 |
| 5 | 17 | |
| 6 | 19 | |
| 7 | 26 | |
| 8 | 20 | |
| 9 | 8 | |
| 10 | 23 | |
| 11 | 5 | |
| 12 | 16 | |
| 13 | 13 |
About Shengshan Xu
Shengshan Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 13 papers that have together received 175 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (43 citations), Oncology (56 citations) and Immunology (37 citations). Shengshan Xu has collaborated with scholars based in China, Hungary and Germany. Frequent co-authors include Zhuming Lu, Youbin Zheng, Hongyu Chu, Min Ye, Xiaoping Li, Jie Yuan, Xin Zhang, Penghui Hu, Shao‐Hua Yang and Xianqiang Liu. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.